Olga Montes-Ares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olga Montes-Ares has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Torío
Sección de Inmunología, Hospital Regional Universitario de Málaga Instituto de Investigación Biomédica de Málaga (IBIMA) Málaga Spain
6 shared publications - Alfredo Minguela
Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain
5 shared publications - Luis Alberto Marin Rubio
Immunology Unit, Clinical Analysis Department Albacete University Hospital Complex Albacete Spain
4 shared publications Manuel Muro
Departments of Immunology
3 shared publications- Antonio Parrado
Servicio de Inmunología, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), El Palmar, 30120 Murcia, Spain
2 shared publications F Sánchez-Bueno
Liver Transplant Unit (F.S.-B., P.P.), University Hospital “Virgen de la Arrixaca,” Murcia, Spain
2 shared publications
Latest Publications
- 1 December 2013
- Published by Elsevier in Transplant Immunology
- Vol. 29 (1-4) , 28-33
Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?
- 1 December 2013
- Published by Elsevier in Transplant Immunology
- Vol. 29 (1-4) , 28-33
Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?
- 1 October 2013
- Published by Elsevier in Inmunología
- Vol. 32 (4) , 148-156
Taller de Autoinmunidad 2013 de la Sociedad Española de Inmunología. Anticuerpos anticitoplasma de neutrófilo (ANCA)
- 1 October 2013
- Published by Elsevier in Inmunología
- Vol. 32 (4) , 148-156
Taller de Autoinmunidad 2013 de la Sociedad Española de Inmunología. Anticuerpos anticitoplasma de neutrófilo (ANCA)
- 1 November 2012
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (9) , 2596-2598
Effect of CYP3A5*1/*3 Polymorphism on Blood Pressure in Renal Transplant Recipients
- 1 November 2012
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (9) , 2596-2598
Effect of CYP3A5*1/*3 Polymorphism on Blood Pressure in Renal Transplant Recipients
- 1 July 2011
- Published by Elsevier in Transplantation Proceedings
- Vol. 43 (6) , 2168-2170
Lack of Association of Immune Cell Function Test With Rejection in Kidney Transplantation
- 1 July 2011
- Published by Elsevier in Transplantation Proceedings
- Vol. 43 (6) , 2168-2170
Lack of Association of Immune Cell Function Test With Rejection in Kidney Transplantation
- Open Access
- 1 November 2006
- Published by Wiley in British Journal of Haematology
- Vol. 135 (4) , 517-519
Human leucocyte antigen-C in B chronic lymphocytic leukaemia
This study aimed at characterising the distribution of human leucocyte antigen (HLA)-C alleles in a large group of patients with B chronic lymphocytic leukaemia from Southeastern Spain. Ninety-eight adult patients and 194 geographically and ethnically matched controls were studied. HLA-C was determined by polymerase chain reaction sequence-specific primers (PCR-SSP) and PCR-sequence-specific oligonucleotides (SSO) methods. The HLA-Cw*16 allele frequency was found to be significantly increased amongst patients compared with controls in our population (27.6% vs. 12.4%, P = 0.0012, Pc = 0.016). HLA-C dimorphism was also analysed but no association was found.
- 1 November 2006
- Published by Wiley in British Journal of Haematology
- Vol. 135 (4) , 517-519
Open AccessHuman leucocyte antigen-C in B chronic lymphocytic leukaemia
This study aimed at characterising the distribution of human leucocyte antigen (HLA)-C alleles in a large group of patients with B chronic lymphocytic leukaemia from Southeastern Spain. Ninety-eight adult patients and 194 geographically and ethnically matched controls were studied. HLA-C was determined by polymerase chain reaction sequence-specific primers (PCR-SSP) and PCR-sequence-specific oligonucleotides (SSO) methods. The HLA-Cw*16 allele frequency was found to be significantly increased amongst patients compared with controls in our population (27.6% vs. 12.4%, P = 0.0012, Pc = 0.016). HLA-C dimorphism was also analysed but no association was found.
- 1 September 2006
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 56 (1) , 7-11
Biochemical and immunologic features of an outbreak of Legionnaires disease: comparative study between community-acquired pneumonias
- 1 September 2006
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 56 (1) , 7-11
Biochemical and immunologic features of an outbreak of Legionnaires disease: comparative study between community-acquired pneumonias
- 20 December 2005
- Published by Springer Nature in Immunogenetics
- Vol. 57 (12) , 926-933
HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis
Available data have led to a controversy on the relationship between human leukocyte antigen (HLA) and cutaneous malignant melanoma susceptibility or prognosis. Moreover, the influence of HLA-C on melanoma has not yet been well established. Therefore, the aim of the current study was to analyze the possible influence of the HLA system on melanoma susceptibility and prognosis in the Spanish population. For this purpose, HLA-A and HLA-B serotyping and HLA-C, HLA-DRB1, and HLA-DQB1 genotyping by polymerase chain reactions using sequence-specific oligonucleotide (PCR-SSO) and sequence-specific primer (PCR-SSP) were performed in 174 melanoma patients and 227 ethnically matched controls. The number of controls was increased up to 356 for HLA-C typing. Patients were stratified according to the histological subtypes of melanoma, sentinel lymph node status, tumor thickness, and ulceration of primary lesion. No HLA-A, HLA-B, HLA-DRB1, or HLA-DQB1 relationship with melanoma was observed for susceptibility or disease prognosis. However, the analysis of HLA-C locus showed that individuals homozygous for HLA-CLys80 were significantly more frequent within the patient than the control group. Remarkably, individuals homozygous for group 2 HLA-C alleles (HLA-CLys80) seem to be associated with metastatic progression of melanoma. In contrast, we found a negative association between group 1 HLA-C alleles (HLA-CAsn80) and disease susceptibility or metastasis development. In conclusion, although an association with HLA-A, HLA-B, HLA-DRB1, or HLA-DQB1 was not demonstrated, the study of the HLA-C locus revealed that the analysis of the dimorphism at position 80 in the α1 helix may help to evaluate the risk and prognosis of melanoma in our population.
- 20 December 2005
- Published by Springer Nature in Immunogenetics
- Vol. 57 (12) , 926-933
HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis
Available data have led to a controversy on the relationship between human leukocyte antigen (HLA) and cutaneous malignant melanoma susceptibility or prognosis. Moreover, the influence of HLA-C on melanoma has not yet been well established. Therefore, the aim of the current study was to analyze the possible influence of the HLA system on melanoma susceptibility and prognosis in the Spanish population. For this purpose, HLA-A and HLA-B serotyping and HLA-C, HLA-DRB1, and HLA-DQB1 genotyping by polymerase chain reactions using sequence-specific oligonucleotide (PCR-SSO) and sequence-specific primer (PCR-SSP) were performed in 174 melanoma patients and 227 ethnically matched controls. The number of controls was increased up to 356 for HLA-C typing. Patients were stratified according to the histological subtypes of melanoma, sentinel lymph node status, tumor thickness, and ulceration of primary lesion. No HLA-A, HLA-B, HLA-DRB1, or HLA-DQB1 relationship with melanoma was observed for susceptibility or disease prognosis. However, the analysis of HLA-C locus showed that individuals homozygous for HLA-CLys80 were significantly more frequent within the patient than the control group. Remarkably, individuals homozygous for group 2 HLA-C alleles (HLA-CLys80) seem to be associated with metastatic progression of melanoma. In contrast, we found a negative association between group 1 HLA-C alleles (HLA-CAsn80) and disease susceptibility or metastasis development. In conclusion, although an association with HLA-A, HLA-B, HLA-DRB1, or HLA-DQB1 was not demonstrated, the study of the HLA-C locus revealed that the analysis of the dimorphism at position 80 in the α1 helix may help to evaluate the risk and prognosis of melanoma in our population.
- 31 October 2005
- Published by Elsevier in Journal of Dermatological Science
- Vol. 40 (1) , 62-64
Lack of association between HLA-E polymorphism and primary cutaneous melanoma in Spanish patients
- 31 October 2005
- Published by Elsevier in Journal of Dermatological Science
- Vol. 40 (1) , 62-64
Lack of association between HLA-E polymorphism and primary cutaneous melanoma in Spanish patients
- 30 August 2003
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (5) , 1892-1893
Impact of HLA-C on acute rejection in liver transplantation
- 30 August 2003
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (5) , 1892-1893
Impact of HLA-C on acute rejection in liver transplantation
- 1 August 2003
- Published by Elsevier in Human Immunology
- Vol. 64 (8) , 811-815
HLA class II genotypic frequencies in atopic asthma
- 1 August 2003
- Published by Elsevier in Human Immunology
- Vol. 64 (8) , 811-815
HLA class II genotypic frequencies in atopic asthma